🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 071813109
- Market Cap
- Large Cap
Business: Baxter International Inc. provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries.
Notes: June 6, 2015 -- Healthcare company Baxter International Inc (BAX) on Friday, June 5th, said its board has approved the planned separation of its biopharmaceuticals business, to be known as Baxalta Inc, and declared a special dividend of 80.5 percent of the outstanding shares of Baxalta common stock. Baxter will retain a 19.5 percent ownership stake in Baxalta immediately following the distribution. For each share of Baxter common stock held of record as of the close of business on June 17, Baxter shareholders will receive one share of Baxalta stock. The special dividend is expected to be paid on July 1. The distribution of Baxalta stock will complete the proposed separation and Baxalta expects to begin trading regular way as an independent company beginning July 1 on the New York Stock Exchange under the ticker symbol BXLT.
Company Contact
- CEO
- Brent Shafer
- CFO
- Cathy R. Smith
- Headquarters
- One Baxter Parkway, Deerfield, IL 60015
- Phone
- 224-948-2000 · Toll-Free 888-359-8645
- Fax
- 224-948-4498
- Investor Relations
- Clare Trachtman · 224-948-3085